On 2018-12-09, the Asian Fund for Cancer Research will be supporting and participating in the Hong Kong Anti-Cancer Society’s full day of Hong Kong Cancer Day programming. Actress Sonija Kwok will be serving as event ambassador, and among the special guests will…
Wang Jiguang (left), assistant professor at the division of life science, department of chemical and biological engineering, HKUST, and Professor Jiang Tao (right) from Beijing Tiantan Hospital, showing results of the clinical trial. Photo: Hong Kong University of Science and Technology
Researchers…
The 2018 USCACA-AFCR Scholar Award Ceremony in Tianjin on November 17, 2018
The Asian Fund for Cancer Research and the US Chinese Anti-Cancer Association have jointly awarded six outstanding Chinese cancer researchers in the early stage of their careers with the 2018 USCACA-AFCR…
The United States Chinese Anti-Cancer Association and AFCR are pleased to invite nominations for the USCACA-AFCR 2018 Scholar Awards.
The Awards will recognize 4 to 5 junior Chinese investigators on the basis of significant contributions in Translational or Clinical Cancer Research.
Candidacy is open to…
With lung cancer continuing to affect the lives of so many people, it’s important to understand the disease and what we can do to improve our chances of beating it.
1. Targeted therapies are showing great promise in treating lung cancer.
If you’ve been…
(clockwise) AFCR Founder and CEO Dr. Sujuan Ba, ECI Founder Mr. Andrew Forrest and PhIRDA Executive President Mr. Song Ruilin
Bringing International Partners Together
In recent months, the Asian Fund for Cancer Research (AFCR) has established relationships with two fellow Pacific Rim institutions: the China…
(Hong Kong, April 13, 2015) Prof. Mingjie Zhang of Hong Kong University of Science and Technology, a scientist supported by the Asian Fund for Cancer Research (AFCR), recently discovered a critical molecular interaction governing epithelial cell polarity – a crucial factor in…
The Asian Fund for Cancer Research (AFCR) is pleased to be an official Contributor for the 2018 Gordon Research Conference (GRC) on nasopharyngeal carcinoma being held at the Hong Kong University of Science and Technology (HKUST) from June 24th to 29th. The…
Anne Li
A vaccine designed to prevent cervical cancer is safe and effective in reducing cell changes that can become cancerous, a new review has confirmed. The human papilloma virus (HPV) vaccine reduces precancerous changes and doesn’t cause serious side effects, according to…
There is a lot of excitement in our market over the new rules we introduced earlier this month to welcome new economy and pre-revenue biotech companies. We’ve already had several companies express interest in listing under the new rules, and we’ve heard…